An edition of Should Pharmaceutical Prices Be Regulated? (1997)

Should Pharmaceutical Prices be Regulated?

The Strengths and Weaknesses of the British Pharmaceutical Price Regulation Scheme (Choice in Welfare 40)

by , , , , , and

Cover of: Should Pharmaceutical Prices be Regulated? by Philip Brown, Elias Mossialos, M. L. Burstall, David G. Green, Reekie, W. Duncan., Heinz Redwood, Philip Brown, Elias Mossialos, M. L. Burstall, David G. Green, Reekie, W. Duncan., Heinz Redwood
Locate

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today
Notes
Notes

Check nearby libraries

Buy this book

Last edited by ImportBot
July 2, 2023 | History
Edit
An edition of Should Pharmaceutical Prices Be Regulated? (1997)

Should Pharmaceutical Prices be Regulated?

The Strengths and Weaknesses of the British Pharmaceutical Price Regulation Scheme (Choice in Welfare 40)

by , , , , , and

This work doesn't have a description yet. Can you add one?

Publish Date
Publisher
Coronet Books
Language
English
Pages
132

Check nearby libraries

Buy this book

Edition Availability
Cover of: Should Pharmaceutical Prices be Regulated?
Should Pharmaceutical Prices be Regulated?: The Strengths and Weaknesses of the British Pharmaceutical Price Regulation Scheme (Choice in Welfare 40)
October 1997, Coronet Books
Paperback in English

Add another edition?

Book Details

The Physical Object

Format
Paperback
Number of pages
132

ID Numbers

Open Library
OL10229299M
ISBN 10
025536430X
ISBN 13
9780255364300
Goodreads
2176036

Source records

Promise Item

Community Reviews (0)

No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
July 2, 2023 Created by ImportBot import existing book